BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19504358)

  • 1. Rapid screening of serum-free media for the growth of adherent Vero cells by using a small-scale and non-invasive tool.
    Petiot E; Fournier F; Gény C; Pinton H; Marc A
    Appl Biochem Biotechnol; 2010 Mar; 160(6):1600-15. PubMed ID: 19504358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an animal-component free medium for vero cells culture.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Biotechnol Prog; 2009; 25(6):1752-61. PubMed ID: 19768803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
    Spens E; Häggström L
    Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
    Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
    Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of factorial design to accelerate identification of CHO growth factor requirements.
    Chun C; Heineken K; Szeto D; Ryll T; Chamow S; Chung JD
    Biotechnol Prog; 2003; 19(1):52-7. PubMed ID: 12573006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characterization of vero cell metabolism in a serum-free batch culture process.
    Petiot E; Guedon E; Blanchard F; Gény C; Pinton H; Marc A
    Biotechnol Bioeng; 2010 Sep; 107(1):143-53. PubMed ID: 20506276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of yellow fever virus in microcarrier-based Vero cell cultures.
    Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR
    Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface immobilized protein multilayers for cell seeding.
    Brynda E; Pacherník J; Houska M; Pientka Z; Dvorák P
    Langmuir; 2005 Aug; 21(17):7877-83. PubMed ID: 16089395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
    Genzel Y; Olmer RM; Schäfer B; Reichl U
    Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-cost serum-free medium for the BTI-Tn5B1-4 insect cell line.
    Donaldson MS; Shuler ML
    Biotechnol Prog; 1998; 14(4):573-9. PubMed ID: 9694678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of growth and recombinant protein expression in two different insect cell lines in attached and suspension culture.
    Taticek RA; Choi C; Phan SE; Palomares LA; Shuler ML
    Biotechnol Prog; 2001; 17(4):676-84. PubMed ID: 11485429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabies virus production in high vero cell density cultures on macroporous microcarriers.
    Yokomizo AY; Antoniazzi MM; Galdino PL; Azambuja N; Jorge SA; Pereira CA
    Biotechnol Bioeng; 2004 Mar; 85(5):506-15. PubMed ID: 14760691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term stability of Vero cell-derived inactivated Japanese encephalitis vaccine prepared using serum-free medium.
    Toriniwa H; Komiya T
    Vaccine; 2008 Jul; 26(29-30):3680-9. PubMed ID: 18534722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of influenza virus in serum-free mammalian cell cultures.
    Merten OW; Manuguerra JC; Hannoun C; van der Werf S
    Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.
    Xie L; Metallo C; Warren J; Pilbrough W; Peltier J; Zhong T; Pikus L; Yancy A; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2003 Jul; 83(1):45-52. PubMed ID: 12740932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEK 293 cell suspension culture using fibronectin-adsorbed polymer nanospheres in serum-free medium.
    Ryu JH; Kim SS; Cho SW; Choi CY; Kim BS
    J Biomed Mater Res A; 2004 Oct; 71(1):128-33. PubMed ID: 15368262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cultivation of Vero cells and human embryonic fibroblasts in serum-free media and in media with a low serum content].
    Nikolaenko NS; Tsupkina NV; Nikitina IuM; Pinaev GP
    Tsitologiia; 1994; 36(8):816-21. PubMed ID: 7701612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.